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Klebsiella pneumoniae is an encapsulated, nonmotile, Gram-negative pathogen of great medical significance that is implicated in a wide variety of infections in humans, including urinary tract infections, pneumonia, bacteremia, meningitis, and liver abscesses ([@B1], [@B2]). Carbapenem-resistant Enterobacteriaceae species, such as K. pneumoniae, are included in the World Health Organization global priority pathogen list, and carbapenems are usually the last-resort antibiotic by virtue of their broad spectrum of activity ([@B3], [@B4]). Here, we present the emergence of sequence type 3136 (ST3136), a novel carbapenem-resistant sequence type isolated from a rectal swab of an adult female patient in an intensive care unit of a public hospital in Durban, South Africa.

A chromogenic screening medium, Chromid Carba Smart (bioMérieux, France), was used for the isolation of the strain. Phenotypic microbial identification and antibiotic susceptibility testing were performed using the Vitek 2 system (bioMérieux, France). The Rapidec Carba NP (bioMérieux, France) test was used to detect carbapenem hydrolysis by carbapenemase-producing bacteria. The strain was grown on nutrient agar (Oxoid, England) and incubated overnight at 37°C prior to genomic DNA extraction. The QIAamp DNA minikit (Qiagen, Germany) was used to extract the total genomic DNA. A paired-end library (2 × 300 bp) was prepared using a Nextera XT DNA sample preparation kit, and whole-genome sequencing (WGS) was carried out on a MiSeq machine (Illumina, USA). The sequenced reads (3,325,060 reads) were quality trimmed using Sickle version 1.33 (<https://github.com/najoshi/sickle>) and *de novo* assembled using SPAdes version 3.11 ([@B5]). All resultant contiguous sequences were then submitted to GenBank, where gene annotation was implemented using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) ([@B6]). Furthermore, the assembled genome was submitted to the Klebsiella multilocus sequence type (MLST) database at Institut Pasteur (Paris, France) (<http://bigsdb.pasteur.fr/klebsiella/klebsiella.html>) to assign the new sequence type ([@B7]). The resistance genes and virulence factors were predicted using ResFinder ([@B8]) through the GoSeqIt tools Web platform (<https://www.goseqit.com/web-services/>) and the VirulenceFinder database (<http://www.mgc.ac.cn/VFs/>) ([@B9]), respectively.

The assembled genome yielded 180 contiguous sequences of longer than 200 bp, covering 5,574,236 bp, with a G+C content of 57.37%, an *N*~50~ value of 103,476 bp, and a longest contig size of 283,489 bp. The total number of 5,771 genes predicted by PGAP includes 5,427 protein-coding genes, 235 pseudogenes, and 109 RNA genes. The novel sequence type was defined as ST3136 by the Klebsiella MLST database (identifier 6431). Acquired antibiotic resistance genes to aminoglycosides \[*aac(6\')Ib-cr, aac(3)-IIa, aac(6\')Ib-cr, aadA16, aph(3\'\')-Ib, aph(3\')-Ia, aph(6)-Id*, and *rmtC*), β-lactams (*bla*~CTX-M-15~, *bla*~NDM-1~, *bla*~OXA-1~, *bla*~SHV-1~, and *bla*~TEM-1B~), fluoroquinolones \[*aac(6\')-Ib-cr, oqxA, oqxB*, and *qnrB6*\], fosfomycin (*fosA*), macrolides \[*mph(A)*\], phenicol (*catA1* and *catB4*), rifampin (*ARR-3*), sulfonamides (*sul1* and *sul2*), and trimethoprim (*dfrA27*) were found, which confirmed the ability of WGS to make accurate resistome predictions. The VirulenceFinder database determined the following virulence factors: type I fimbriae (*fimG*) and type III fimbriae (*mrkA, mrkB, mrkC, mrkD*, and *mrkF*), lipoproteins (*pulG, pulO*, and *pulS*), and capsular polysaccharides (*wza, wzc*, and *wzi*), which contribute to the bacterium's ability to adhere to, lyse, and invade host tissues, respectively ([@B10]). The valuable information offered by genomics provides a good step toward a better understanding of the pathogenicity of multidrug-resistant strains.

This study was approved by the Biomedical Research Ethics Committee (approval BE453/15) of the College of Health Sciences, University of KwaZulu-Natal (UKZN).
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This whole-genome shotgun project has been deposited in DDBJ/ENA/GenBank under the accession no. [QMCA00000000](https://www.ncbi.nlm.nih.gov/nuccore/QMCA00000000). The version described in this paper is version QMCA01000000. The raw sequencing reads have been submitted to the SRA under the accession no. [SRR8079358](https://www.ncbi.nlm.nih.gov/sra/SRR8079358).
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